Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women

Clinical Science

Volumn 101, Issue 5, 2001, Pages 447-453

  Maffei, S ^a   Del Ry, S ^a   Prontera, C ^a   Clerico, A ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

ANP; BNP; Hormone replacement therapy; IRMA; Natriuretic peptides; Oestrogens; Progesterone

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DIHYDROGESTERONE; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; HORMONE; LUTEINIZING HORMONE; STEROID HORMONE; UNCLASSIFIED DRUG;

ADULT; ARTERIAL PRESSURE; ARTICLE; BODY WEIGHT; CLIMACTERIUM; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HEART PROTECTION; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; IMMUNORADIOMETRIC ASSAY; LUTEINIZING HORMONE BLOOD LEVEL; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

20-ALPHA-DIHYDROPROGESTERONE; ADMINISTRATION, CUTANEOUS; ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; CHEMILUMINESCENT MEASUREMENTS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; POSTMENOPAUSE;

EID: 0034768203     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20010039     Document Type: Article

References (34)

1. Estrogen, natriuretic peptides and the renin-angiotensin system
2. Cardioprotective effects of ovarian hormones
3. The effects of hormone replacement therapy on coronary heart disease
4. Menopause and hormone replacement therapy
5. Hormone replacement therapy
6. Age-associated changes in the cardiovascular system in the absence of cardiovascular disease
7. Hormonal alterations in heart failure
8. Clinical relevance of the measurement of cardiac natriuretic peptide hormones in humans
9. Circulating levels of cardiac natriuretic hormones measured in women during menstrual cycle
10. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
11. A new, fast, and reliable radioimmunoassay of brain natriuretic peptide in human plasma; reference values in healthy subjects and in patients with different diseases
12. Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an IRMA method
13. Effect of atrial natriuretic peptide on renal hemodynamics and sodium excretion during human pregnancy
14. Release of atrial natriuretic peptide during pregnancy and immediate puerperium
15. Atrial natriuretic peptide - The influence of various physiological and sampling conditions
16. Atrial natriuretic peptide during menstrual cycle
17. The influence of gender, age, and the menstrual cycle on plasma atrial natriuretic peptide
18. Atrial natriuretic peptide, oestradiol and progesterone in women undergoing spontaneous and gonadotropin-stimulated ovulatory cycles
19. Vasopressin and atrial natriuretic hormone response to hypertonic saline during the follicular and luteal phases of the menstrual cycle
20. Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women
21. Atrial natriuretic peptide, plasma renin activity, and aldosterone in women on estrogen therapy and with premenstrual syndrome
22. Analytical performance and clinical usefulness of a commercially available IRMA kit for the measurement of atrial natriuretic peptide in patients with heart failure
23. ANP kinetics in normal men: In vivo measurement by a tracer method and correlation with sodium intake
24. Altered tissue degradation and distribution of atrial natriuretic peptide in patients with idiopathic dilated cardiomyopathy and its relationship with clinical severity of the disease and sodium handling
25. Immunoassay methods for the measurement of natriuretic cardiac hormones (ANP, BNP, and related peptides) in humans
26. Measurement of natriuretic cardiac hormones (ANP, BNP, and related peptides) in clinical practice: The need for a new generation of immunoassay methods
27. Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: How do they relate to the resistance to atrial natriuretic peptides?
28. Mechanical and neuroendocrine regulation of the endocrine heart
29. Measurement and significance of circulating natriuretic peptides in cardiovascular diseases
30. Turnover studies on cardiac natriuretic peptides: Methodological, pathophysiological and therapeutical considerations
31. Cardiovascular effect of sex hormones
32. Possibility of age regulation of the natriuretic peptide C-receptor in human platelets
33. C-type natriuretic peptide: The endothelial component of the natriuretic peptide system